Rudel LL, Lee RG, Cockman TL. Acyl coenzyme A: cholesterol acyltransferase types 1 and 2: structure and function in atherosclerosis. Curr Opin Lipido. 2001;12:121–7.
Parini P, Davis M, Lada AT, Erickson SK, Wright TL, Gustafsson U, et al. ACAT2 is localized to hepatocytes and is the major cholesterol-esterifying enzyme in human liver. Circulation. 2004;110:2017–23.
Article CAS PubMed Google Scholar
Bhattacharjee P, Rutland N, Iyer MR. Targeting Sterol O-Acyltransferase/Acyl-CoA:Cholesterol Acyltransferase (ACAT): a perspective on small-molecule inhibitors and their therapeutic potential. J Med Chem. 2022;65:16062–98.
Article CAS PubMed Google Scholar
Ohshiro T, Rudel LL, Omura S, Tomoda H. Selectivity of microbial acyl-CoA: cholesterol acyltransferase inhibitors toward isozymes. J Antibiot. 2007;60:43–51.
Krautbauer S, Weiss TS, Wiest R, Schacherer D, Liebisch G, Buechler C. Diagnostic value of systemic cholesteryl ester/free cholesterol ratio in hepatocellular carcinoma. Anticancer Res. 2017;37:3527–35.
Yue S, Li J, Lee SY, Lee HJ, Shao T, Song B, et al. Cholesteryl ester accumulation induced by PTEN loss and PI3K/AKT activation underlies human prostate cancer aggressiveness. Cell Metab. 2014;19:393–406.
Article CAS PubMed PubMed Central Google Scholar
Geng F, Cheng X, Wu X, Yoo JY, Cheng C, Guo JY, et al. Inhibition of SOAT1 suppresses glioblastoma growth via blocking SREBP-1-mediated lipogenesis. Clin Cancer Res. 2016;22:5337–48.
Article CAS PubMed PubMed Central Google Scholar
Smith DC, Kroiss M, Kebebew E, Habra MA, Chugh R, Schneider BJ, et al. A phase 1 study of nevanimibe HCl, a novel adrenal-specific sterol O-acyltransferase 1 (SOAT1) inhibitor, in adrenocortical carcinoma. Invest N. Drugs. 2020;38:1421–9.
Lada AT, Davis M, Kent C, Chapman J, Tomoda H, Omura S, et al. Identification of ACAT1- and ACAT2-specific inhibitors using a novel, cell-based fluorescence assay: individual ACAT uniqueness. J Lipid Res. 2004;45:378–86.
Article CAS PubMed Google Scholar
Sun B-D, Houbraken J, Frisvad J, Jiang X, Chen A, Samson R. New species in Aspergillus section Usti and an overview of Aspergillus section Cavernicolarum. Int J Syst Evol Microbiol. 2020;70:5401–16.
Hu Z, Chen J, Liu Q, Wu Q, Chen S, Wang J, et al. Cyclohexenone derivative and drimane sesquiterpenes from the seagrass-derived fungus Aspergillus insuetus. Chem Biodivers. 2023;20:e202300424.
Article CAS PubMed Google Scholar
Gui P, Fan J, Zhu T, Fu P, Hong K, Zhu W. Sesquiterpenoids from the Mangrove-Derived Aspergillus ustus 094102. Mar Drugs. 2022;20:408.
Article CAS PubMed PubMed Central Google Scholar
Neuhaus GF, Loesgen S. Antibacterial Drimane Sesquiterpenes from Aspergillus ustus. J Nat Prod. 2021;84:37–45.
Article CAS PubMed Google Scholar
Lu Z, Wang Y, Miao C, Liu P, Hong K, Zhu W. Sesquiterpenoids and benzofuranoids from the marine-derived fungus Aspergillus ustus 094102. J Nat Prod. 2009;72:1761–7.
Article CAS PubMed Google Scholar
Hayes MA, Wrigley SK, Chetland I, Reynolds EE, Ainsworth AM, Renno DV, et al. Novel drimane sesquiterpene esters from Aspergillus ustus var. pseudodeflectus with endothelin receptor binding activity. J Antibiot. 1996;49:505–12.
Uosaki Y, Yoshida M, Ogawa T, Saitoh Y. RES-1149-1 and -2, novel non-peptidic endothelin type B receptor antagonists produced by Aspergillm sp. J Antibiot. 1996;49:6–12.
Huang Y, Hoefgen S, Valiante V. Biosynthesis of fungal drimane-type sesquiterpene esters. Angew Chem Int Ed. 2021;60:23763–70.
Ohshiro T, Kobayashi K, Ohba M, Matsuda D, Rudel LL, Takahashi T, et al. Selective inhibition of sterolO-acyltransferase 1 isozyme by beauveriolide III in intact cells. Sci Rep. 2017;7:4163.
Article PubMed PubMed Central Google Scholar
Ogawa T, Ando K, Tanaka T, Uosaki Y, Matsuda Y. RES-1149-1 and -2, novel non-peptidic endothelin type B receptor antagonists produced by Aspergillus sp. I. Taxonomy of producing strain, fermentation, isolation, and physico-chemical and biological properties. J Antibiot. 1996;49:1–5.
Huang Y, Jin Q, Su M, Ji F, Wang N, Zhong C, et al. Leptin promotes the migration and invasion of breast cancer cells by upregulating ACAT2. Cell Oncol. 2017;40:537–47.
Oni TE, Biffi G, Baker LA, Hao Y, Tonelli C, Somerville TDD, et al. SOAT1 promotes mevalonate pathway dependency in pancreatic cancer. J Exp Med. 2020;217:e20192389.
Article PubMed PubMed Central Google Scholar
Jiang Y, Sun A, Zhao Y, Ying W, Sun H, Yang X, et al. Proteomics identifies new therapeutic targets of early-stage hepatocellular carcinoma. Nature. 2019;567:257–61.
Article CAS PubMed Google Scholar
Zhu T, Wang Z, Zou T, Xu L, Zhang S, Chen Y et al. SOAT1 Promotes Gastric Cancer Lymph Node Metastasis Through Lipid Synthesis. Front Pharmacol 2021; 12.
Ren M, Xu H, Xia H, Tang Q, Bi F. Simultaneously targeting SOAT1 and CPT1A ameliorates hepatocellular carcinoma by disrupting lipid homeostasis. Cell Death Discov. 2021;7:125.
Comments (0)